Kisspeptin reading list
The discovery experiments, the timing studies and the trials with an outcome worth lingering over.
Discovery and receptor function
The melanoma gene experiment and the human GPR54 puberty findings make a striking pair. For the question of duration, add the activating receptor mutation. The KISS1 loss-of-function family study concerns the peptide's own gene.
For a closer experimental view of signal transmission, the mouse GnRH-neuron work examines electrical responses in brain slices. It provides cellular context while retaining its mouse, in-vitro setting.
Hormone timing
I would start this group with the evoked LH pulse in healthy men and the response that diminished during repeated exposure. The infusion experiment in hypothalamic amenorrhea and KISS1R pharmacology review extend the timing question. The early kisspeptin-54 study in healthy men supplies a useful hormonal starting point.
Clinical experiments
The IVF trial in women at high OHSS risk sits beside work on cells collected during IVF. For desire, there is the trial in men with hypoactive sexual desire disorder and the visual and olfactory cue experiment.
I give the food-intake experiment and anxiety trial equal billing. Their unchanged outcomes sharpen the subject. The clinical-status systematic review provides a broader survey, with a literature search ending in Feb 2023.
- KiSS-1, a novel human malignant melanoma metastasis-suppressor gene ↗
- The GPR54 gene as a regulator of puberty ↗
- A GPR54-activating mutation in a patient with central precocious puberty ↗
- Inactivating KISS1 mutation and hypogonadotropic hypogonadism ↗
- Kisspeptin excites gonadotropin-releasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels ↗
- Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males ↗
- Kisspeptin resets the hypothalamic GnRH clock in men ↗
- Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis ↗
- Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of kisspeptin-54 ↗
- KISS1R: Hallmarks of an Effective Regulator of the Neuroendocrine Axis ↗
- Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy ↗
- The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function ↗
- Effects of kisspeptin on sexual brain processing and penile tumescence in men with hypoactive sexual desire disorder: a randomized clinical trial ↗
- Kisspeptin enhances brain responses to olfactory and visual cues of attraction in men ↗
- The effects of kisspeptin on food intake in women with overweight or obesity ↗
- Kisspeptin administration stimulates reproductive hormones but does not affect anxiety in humans ↗
- Kisspeptin and its current clinical status - a systematic review ↗